1Kumar A, Taliyan R, Sharma PL. Evaluation of thyroid hormone induced pharmacological preconditioning on cardiomyocyte protection against ischemic-reperfusion injury [J]. Indian J Pharmacol, 2012, 44(1) : 68-72.
2Vogt S, Portig I, Irqsusi M, et al. Heat shock protein expression and change of eytochrome c oxidase activity~ presence of two phylogenic old systems to protect tissues in ischemia and reperfusion[J]. J Bioenerg Biomembr, 2011, 43 (4): 425-435.
3Cross HR, Murphy E, Bolli R, et al. Expression of activated PKC epsilon (PKC epsilon) protects the ischemic heart, without attenuating ischemie H ( + ) production[J]. J Mol Cell Cardiol, 2002, 34(3): 361 -367.
4Dreixler JC, Shaikh AR, Shenoy SK, et al. Protein kinase C subtypes and retinal ischemic preconditioning[J]. Exp Eye Res, 2008, 87(4);300-311.
5Pantos CI, Malliopoulou VA, Mourouzis IS, et al. Long- term thyroxine administration protects the heart in a pattern similar to isehemie preconditioning[J]. Thyroid, 2002, 12 (4) :325-329.
6Mackay K, Mochly-Rosen D. An inhibitor of p38 mitogen- activated protein kinase protects neonatal cardiac myocytes from ischemia[J]. J Biol Chem, 1999, 274(10) : 6272-6279.
7Downey JM, Cohen MV, Cokkinos DV, et al. lschemic preconditioning in myocardial Ischemia~ from Mechanisms to Therapeutic Potentials[M]. New York,2008, 99- 112.
8Pantos C, Xinaris C, Mourouzis I, et al. Thyroid hormone changes cardiomyocyte shape and geometry via ERK signaling pathway: potential therapeutic implications in reversing cardiac remodeling?[J]. Mol Cell Biochem, 2007, 297(1-2) : 65-72.
9Sun Y, MacRae TH. The small heat shock proteins and their role in human disease[J]. FEBS J, 2005, 272 (11): 2613-2627.
10Huot J, Houle F, Spitz DR, et al. HSP27 phosphorylation- mediated resistance against aetin fragmentation and cell death induced by oxidative stress[J]. Cancer Res, 1996, 56(2): 273-279.
